Alternate Insurance Arrangements and the Treatment of Depression: What are the Facts?
22 Pages Posted: 11 Jul 2000 Last revised: 22 May 2022
Date Written: November 1996
Abstract
Using insurance claims data from nine large self-insured employers offering 26 alternative health benefit plans, we examine empirically how the composition and utilization for the treatment of depression vary under alternative organizational forms of insurance (indemnity, preferred provider organization networks or PPOs, and mental health carve-outs), and variations in patient cost-sharing (copayments for psychotherapy and for prescription drugs). Although total outpatient mental health/substance abuse (MHSA) expenditures per treated individual do not vary significantly across insurance forms, the depressed outpatient is more likely to receive anti-depressant drug (ADD) medications in PPOs and carve-outs than under indemnity insurance. Those individuals facing higher copayments for psychotherapy are more likely to receive ADD medications. For those receiving ADD treatment, increases in prescription drug copay tend to increase the share of ADD medication costs accounted for by the newest (and more costly) generation of drugs, the selective serotonin reuptake inhibitors.
Suggested Citation: Suggested Citation
Do you have a job opening that you would like to promote on SSRN?
Recommended Papers
-
Measurement Error in the Consumer Price Index: Where Do We Stand?
By David E. Lebow and Jeremy B. Rudd
-
Price Indexes for the Treatment of Depression
By Richard G. Frank, Ernst R. Berndt, ...
-
By Ernst R. Berndt, Anupa Bir, ...
-
Price Indexes for Acute Phase Treatment of Depression
By Ernst R. Berndt, Susan H. Busch, ...
-
The Boskin Commission Report: A Retrospective One Decade Later
-
Price Indexes for Medical Care Goods and Services: an Overview of Measurement Issues
By Ernst R. Berndt, David M. Cutler, ...
-
Pricing Heart Attack Treatments
By David M. Cutler, Joseph P. Newhouse, ...
-
Adolescent Depression: Diagnosis, Treatment, and Educational Attainment
-
Quality-Constant Price Indexes for the Ongoing Treatment of Schizophrenia: An Exploratory Study
By Richard G. Frank, Ernst R. Berndt, ...